Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway

Fanconi anemia (FA) is an autosomal recessive disorder characterized by congenital abnormalities, bone marrow failure, chromosome fragility, and cancer susceptibility. At least eleven members of the FA gene family have been identified using complementation experiments. Ubiquitin-proteasome has been shown to be a key regulator of FA proteins and their involvement in the repair of DNA damage. Here, we identified a novel functional link between the FA/BRCA pathway and E2F-mediated cell cycle regulome. In silico mining of a transcriptome database and promoter analyses revealed that a significant number of FA gene members were regulated by E2F transcription factors, known to be pivotal regulators of cell cycle progression – as previously described for BRCA1. Our findings suggest that E2Fs partly determine cell fate through the FA/BRCA pathway.

[1]  Kenichi Yoshida,et al.  Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in Hela cells , 2006, Journal of cellular physiology.

[2]  Kenichi Yoshida,et al.  CDCA4 Is an E2F Transcription Factor Family-induced Nuclear Factor That Regulates E2F-dependent Transcriptional Activation and Cell Proliferation* , 2006, Journal of Biological Chemistry.

[3]  P. Glazer,et al.  Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites , 2006, Cancer biology & therapy.

[4]  F. Sigaux,et al.  Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. , 2005, Blood.

[5]  Yanbin Dong,et al.  Gene expression profiling of E2F-1-induced apoptosis. , 2005, Gene.

[6]  R. Young,et al.  A common set of gene regulatory networks links metabolism and growth inhibition. , 2004, Molecular cell.

[7]  K. Helin,et al.  E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.

[8]  Ituro Inoue,et al.  Regulation of Geminin and Cdt1 expression by E2F transcription factors , 2004, Oncogene.

[9]  Kristian Helin,et al.  Identification of Target Genes of the p16INK4A-pRB-E2F Pathway* , 2003, Journal of Biological Chemistry.

[10]  M. Oberley,et al.  E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9* , 2003, Journal of Biological Chemistry.

[11]  C. Bishop,et al.  A novel ubiquitin ligase is deficient in Fanconi anemia , 2003, Nature Genetics.

[12]  Alan D. D'Andrea Fanconi anemia , 2003, Current Biology.

[13]  C. Mathew,et al.  Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.

[14]  C. Mathew,et al.  Interaction of FANCD2 and NBS1 in the DNA damage response , 2002, Nature Cell Biology.

[15]  Hans Joenje,et al.  Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.

[16]  Tim Hui-Ming Huang,et al.  Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. , 2002, Genes & development.

[17]  Hans Joenje,et al.  The emerging genetic and molecular basis of Fanconi anaemia , 2001, Nature Reviews Genetics.

[18]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[19]  R. Moses,et al.  Positional cloning of a novel Fanconi anemia gene, FANCD2. , 2001, Molecular cell.

[20]  M. Macleod,et al.  Regulation of BRCA1 Expression by the Rb-E2F Pathway* , 2000, The Journal of Biological Chemistry.

[21]  Huichen Wang,et al.  BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases , 1997, Oncogene.

[22]  W. Liebetrau,et al.  p53 activates Fanconi anemia group C gene expression. , 1997, Human molecular genetics.

[23]  M. Buchwald,et al.  Characterization of the 5' region of the Fanconi anaemia group C (FACC) gene. , 1995, Human molecular genetics.

[24]  W. R. Shannon,et al.  Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.

[25]  A. D’Andrea,et al.  The Fanconi anaemia/BRCA pathway , 2003, Nature Reviews Cancer.